Syllabus database for doctoral courses

    Startpage
  • Syllabus database for doctoral courses

SYLLABI FOR DOCTORAL COURSES

Print
Swedish title Läkemedelsforskning och -utveckling
English title Drug discovery and development
Course number 2884
Credits 3.0
Responsible KI department Institutionen för klinisk neurovetenskap
Specific entry requirements
Grading Passed /Not passed
Established by The Board of Doctoral Education
Established 2015-09-22
Purpose of the course
Intended learning outcomes After the course, students must be able to (1) account for the drug discovery and development process including the various scientific and business disciplines involved as well as the issues and challenges facing this industry; (2) discuss the major unmet needs in this field and the scientific gaps challenging the ability to address those unmet needs; (3) account for and critically discuss the development of translational tools that can be used to predict efficacy of drug candidates in preclinical and early clinical studies; (4) discuss the regulatory and commercial challenges to developing new therapies and how segmentation strategies using biomarkers can be used; (5) show an understanding of the commercial aspects of drug development including the importance of intellectual property rights; and (6) demonstrate an awareness of the opportunities and challenges of other possibilities to commercialize research findings, beyond drug projects.
Contents of the course (1) A series of lectures addressing major aspects of Drug Discovery and Development with a particular focus on the challenges of translation from preclinical to early and late clinical development. The course will highlight experts in the range of disciplines involved in the drug discovery and development process and the translational tools related to developing new therapies to treat diseases. The course will also address the technical and clinical aspects of validation of biomarkers needed before applied in the different aspects of drug development. Additionally, the course will address other avenues for entrepreneurship arising for research in the neurosciences.
(2) Group exercises where the students develop plans for a drug discovery and development project.
Teaching and learning activities Lectures, seminars, and group exercises including presentations. The participants will get questions to reflect upon before the seminars.
Compulsory elements Seminars and group presentations.
Examination An oral presentation of the group exercises will count as an examination. We will assess the individual students' ability to develop a realistic plan for the project, as well as his or her ability to critically discuss current challenges in the field.
Literature and other teaching material Recent journal articles distributed prior to the lectures
Course responsible Edwin Johnson
Institutionen för klinisk neurovetenskap
08-524 830 82
070-745 97 61
edwin.johnson@ki.se

Contact person Louise Von Essen
Institutionen för klinisk neurovetenskap
58483042
0736883259
Louise.Von.Essen@ki.se